Harvey G. Klein, MD; Willy A. Flegel, MD; Charles Natanson, MD
JAMA. 2015;314(15):1557-1558. doi:10.1001/jama.2015.10890
This Viewpoint discusses how new technologies could be developed and applied to the decision to transfuse.
Philip Rocco, PhD; Walid F. Gellad, MD, MPH; Julie M. Donohue, PhD
JAMA. 2015;314(15):1559-1560. doi:10.1001/jama.2015.10979
This Viewpoint discusses CMS’ proposed overhaul of Medicaid’s managed care programs.
Caroline Kistin, MD, MSc; Michael Silverstein, MD, MPH
JAMA. 2015;314(15):1561-1562. doi:10.1001/jama.2015.10962
This Viewpoint discusses the goals of pilot studies as precursors to large-scale trials as well as the need for formal guidelines for the conduct and reporting of pilot trials.
Jing Luo, MD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2015;314(15):1563-1564. doi:10.1001/jama.2015.10872
This Viewpoint discusses the importance of patent protection and its role in the Trans-Pacific Partnership (TPP) Agreement.
Yael Schenker, MD, MAS; Robert Arnold, MD
JAMA. 2015;314(15):1565-1566. doi:10.1001/jama.2015.11217
This Viewpoint urges the development of systems to help patients with serious illness and their families understand palliative care options.